Clik here to view.
Boehringer Admits Pradaxa Bleeding Deaths Higher than Revealed to FDA
Pradaxa’s manufacturer failed to inform the FDA that Pradaxa bleeding deaths were higher after the drug’s approval than in the study the company submitted to obtain agency authorization, according to a...
View ArticleClik here to view.
Judge Delays Start of Pradaxa Bellwether Trials
The first of four Pradaxa injury lawsuits scheduled for early trial dates in the Southern District of Illinois have been delayed. U.S. District Judge David R. Herndon deferred the start date by about...
View ArticleClik here to view.
Boehringer Ingelheim Fined for Discovery Abuses in Pradaxa Litigation
The federal judge presiding over Pradaxa lawsuits coordinated in MDL 2385 has imposed sanctions on Boehringer Ingelheim for several discovery abuses. U.S. District Judge David R. Herndon has ordered...
View ArticleClik here to view.
Pradaxa Gastrointestinal Bleed Lawsuit Filed in Texas
A Texas man has filed a Pradaxa gastrointestinal bleed lawsuit against the manufacturer of the drug, Boehringer Ingelheim Pharmaceuticals, Inc. Arthur G. Hill claims the drug caused him to experience...
View ArticleClik here to view.
Pradaxa Bleeding Antidote Announced in Study
Researchers may have found an antidote for the Pradaxa bleeding side effects that have reportedly caused hundreds of deaths since the drug’s introduction to the U.S. market in October of 2010. The...
View ArticleClik here to view.
Boehringer Faces New Pradaxa Death Lawsuit
Yet another Pradaxa death lawsuit has been filed in Minnesota as more and more plaintiffs come forward with allegations that the defendant, Boehringer Ingelheim, Inc., fraudulently concealed the fact...
View ArticleClik here to view.
Pradaxa MDL Proceeds with First Bellwether Trial
The first of the Pradaxa lawsuits to go to trial in multidistrict litigation (MDL) will be the complaint filed by Suzanne Mackiewicz. This plaintiff filed her lawsuit on behalf of her father, Malachy...
View ArticleClik here to view.
Louisiana Woman Files Pradaxa Wrongful Death Lawsuit
Rosalie Recchia filed a Pradaxa wrongful death lawsuit on behalf of Philip Recchia on April 14, 2014. The complaint was filed in the United States District Court of Minnesota. Recchia was a resident of...
View ArticleClik here to view.
Despite Severe Pradaxa Side Effects, Drug is Approved for Additional Indications
The FDA has extended use of the blood-thinning medication Pradaxa to include patients diagnosed with or at risk of deep vein thrombosis (DVT) or pulmonary embolism (PE). The drug has been used in the...
View ArticleClik here to view.
Blood-Thinner Report Contested by Manufacturers
In February, a report issued by AdverseEvents, a healthcare information organization, evaluated the risk of bleeding problems with Pradaxa, Xarelto, and Eliquis. It compiled its data based on adverse...
View ArticleClik here to view.
FDA Says Pradaxa Stomach Bleed Risk Higher Than Warfarin
The FDA has released an updated drug safety communication indicating that the anticoagulant dabigatran (Pradaxa), while offering certain benefits, carries an increased risk of major gastrointestinal...
View ArticleClik here to view.
93-Year-Old Sunday School Teacher Dead One Week after Using Pradaxa
On January 24, 2012, one week after being prescribed Pradaxa, the anticoagulant medication, Ms. Thelma Suber, a 93-year-old Sunday school teacher from South Carolina, died of an uncontrollable...
View ArticleClik here to view.
$650 Million Pradaxa Settlement Ends Legal Ordeal for 4000 Victims
One day after a committee of eight plaintiffs’ attorneys was named by US District Judge David Herndon to negotiate a master Pradaxa settlement with the manufacturer Boehringer Ingelheim, the German...
View ArticleClik here to view.
Despite Serious Pradaxa Side Effects, British Health Agency Pushes Use
Despite increasing reports of serious Pradaxa side effects, a British health agency is recommending more widespread use of the drug as treatment for atrial fibrillation. The National Institute for...
View ArticleClik here to view.
FDA Calls Pradaxa Reversal Agent “Breakthrough”
According to a recent press release by Pradaxa manufacturer Boehringer Ingelheim Pharmaceuticals, the Federal Drug Administration (FDA) has granted Breakthrough Therapy Designation to an in-the-works...
View ArticleClik here to view.
Report Suggests Boehringer Withheld Crucial Info on Pradaxa Dose Monitoring
An investigation conducted by the British Medical Journal (BMJ) finds that Pradaxa manufacturer Boehringer Ingelheim withheld crucial information from health regulators regarding the safety of its...
View ArticleClik here to view.
Pradaxa Lawsuit Plaintiff Suffers Embolic Stroke
According to allegations raised in a recent product liability case against Boehringer Ingelheim, the plaintiff suffered a massive embolic stroke as a direct result of taking the defendant’s...
View ArticleClik here to view.
Two Daughters File Pradaxa Brain Bleed Lawsuit
Two Massachusetts daughters have filed a Pradaxa brain bleed lawsuit against the international pharmaceutical giant, Boehringer Ingelheim, for the wrongful death of their father in November 2012. The...
View ArticleClik here to view.
Pradaxa Death Lawsuit Brought in Louisiana Federal Court
According to charges in a recent Pradaxa death lawsuit, the defendant’s blood thinner medication caused the plaintiffs’ decedent to suffer fatal injuries. Boehringer Ingelheim Pharmaceuticals designs,...
View ArticleClik here to view.
Pradaxa Stroke Lawsuit Alleges Failure to Warn
Many lawsuits filed against Boehringer Ingelheim with regard to its medication Pradaxa (dabigatran) allege that the drug results in irreversible bleeding events, which have reportedly caused the...
View Article